Us Congress 2023-2024 Regular Session

Us Congress House Bill HB9785

Introduced
9/24/24  

Caption

CLAWS Act of 2024 Chinese Laboratory Accountability and Watchful Spending Act of 2024

Impact

The implementation of HB 9785 could significantly alter existing protocols around federal funding for laboratory initiatives. It emphasizes accountability from Chinese laboratories and encourages potential collaboration with local entities under stricter scrutiny. Proponents argue that these measures are crucial for protecting national interests and ensuring responsible spending. The bill's requirement for transparency may lead to more rigorous evaluations of laboratory activities, which could affect funding dynamics and operational strategies within these institutions.

Summary

House Bill 9785, referred to as the Chinese Laboratory Accountability and Watchful Spending Act of 2024, seeks to establish rigorous oversight mechanisms regarding federal spending and accountability for funds allocated to laboratories associated with Chinese entities. The bill aims to enhance transparency and ensure that taxpayer money is not misused, particularly in areas relating to national security and public health. By instituting stringent reporting requirements, the legislation intends to provide a clearer picture of how funds are being utilized within these laboratories, especially in research and development activities.

Contention

Despite its intended goals, HB 9785 has sparked debates around the implications of restricting funding and oversight on international collaborations in scientific research. Critics raise concerns that overly stringent regulations could hinder important scientific work and discourage partnerships crucial for advancements in various fields. Additionally, opponents fear that targeting laboratories based on their associations could lead to broader implications for academic freedom and open scientific inquiry. The balance between ensuring accountability and fostering an open research environment will likely be a point of contention as the bill moves forward.

Companion Bills

No companion bills found.

Previously Filed As

US SB5255

CLAWS Act of 2024 Chinese Laboratory Accountability and Watchful Spending Act of 2024

US HB9674

Judiciary Accountability Act of 2024

US HB510

Chinese Currency Accountability Act of 2023

US HB9803

Hospice CARE Act of 2024 Hospice Care Accountability, Reform, and Enforcement Act of 2024

US SB5168

Judiciary Accountability Act of 2024

US HB1518

Unauthorized Spending Accountability Act of 2023

US SB5016

Combat Chinese Economic Aggression Act of 2024

US HB6642

GRANT Act of 2023 Grant Recipient Accountability for Necessary Transparency Act of 2023

US HB747

Stop Chinese Fentanyl Act of 2025

US SB5239

AWARE Act of 2024 Artificial Intelligence Weapon Accountability and Risk Evaluation Act of 2024

Similar Bills

CA AB922

Reproductive health and research: oocyte procurement.

HI SB2304

Relating To The Research Corporation Of The University Of Hawaii.

HI SB3208

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1511

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1511

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1204

Relating To The University Of Hawaii.

CA SB934

California Childhood Cancer Research Fund Act.

CA AB1103

Controlled substances: research.